Algernon PharmaceuticalsAGN 
$0.07-5.00%24h
-5.00%24h
Global rank36502
Market cap$1.06M
Change 7d-9.52%
YTD Performance35.71%
SP500 benchmarkOutperform
P/E-0.16
P/S0
Revenue$0
Earnings-$4.98M
Dividend yield-
Main Sector
Healthcare
Category
Algernon Pharmaceuticals (AGN) Total Liabilities
AGN Total Liabilities in 2022: $2.00M
According to Algernon Pharmaceuticals latest financial reports the total liabilities of AGN is $2.00M, an increase of 8.09% to 2022. At the end of 2022 company had $1.85M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Algernon Pharmaceuticals is responsible for during its operational activities.
Algernon Pharmaceuticals (AGN) Total Liabilities History from 2023 to 2022
-
Value:-
AGN Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $2.00M | 8.09% |
| 2022 | $1.85M | 146.12% |
| 2021 | $750.90K | 68.41% |
| 2020 | $445.89K | 66.10% |
| 2019 | $268.44K | - |
View the Top Total Liabilies Stocks
